Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Synthetic double-stranded short interfering RNA oligonucleotide directed against proopiomelanocortin

EU orphan designation number: EU/3/10/798   
Active ingredient: Synthetic double-stranded short interfering RNA oligonucleotide directed against proopiomelanocortin
Indication: Treatment of adrenocorticotropin-dependent Cushing's syndrome
Sponsor: Diurnal Limited
Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/2010 Orphan designation EMA/OD/038/10 (2010)6943 of 01/10/2010
21/09/2012 Transfer of orphan designation EMA/OD/038/10/T/01 (2012)6516 of 14/09/2012
18/10/2016 Transfer of orphan designation EMA/OD/038/10/T/02 (2016)6729 of 14/10/2016